Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
received her first dose of GARDASIL-9 when she was 11 years old and is now 15 years old. Patient has not received her second dose.; No additional AE.; This spontaneous report was received from a registered nurse and referred to a child female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, when the patient was 11-year-old, she was vaccinated with the first dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) (dose, strength, formulation, route, anatomical site, expiration date and lot# were not reported) for prophylaxis. The patient was now 15 years old and had not received her second dose of the vaccine (inappropriate schedule of product administration). No additional adverse event (no adverse event). The outcome of the events was unknown. Lot# is being requested and will be submitted if received.